Penserra Capital Management LLC Veracyte, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$36.09 - $53.79 $58,285 - $86,870	-1,615 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $3,027 - $4,502	85 Added 5.56%	1,615 $75,000
Q2 2021 Aug 12, 2021	BUY	$32.94 - $56.62 $494 - $849	15 Added 0.99%	1,530 $61,000
Q1 2021 May 13, 2021	BUY	$44.47 - $81.38 $8,226 - $15,055	185 Added 13.91%	1,515 $81,000
Q4 2020 Feb 12, 2021	BUY	$32.49 - $61.88 $27,486 - $52,350	846 Added 174.79%	1,330 $65,000
Q3 2020 Nov 13, 2020	BUY	$26.73 - $35.67 $12,937 - $17,264	484 New	484 $15,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.